| Cytokines in the Treatment of Cancer KC Conlon, MD Miljkovic, TA Waldmann Journal of Interferon & Cytokine Research 39 (1), 6-21, 2019 | 537 | 2019 |
| IL-15 in the combination immunotherapy of cancer TA Waldmann, S Dubois, MD Miljkovic, KC Conlon Frontiers in immunology 11, 868, 2020 | 194 | 2020 |
| IL15 by continuous intravenous infusion to adult patients with solid tumors in a phase I trial induced dramatic NK-cell subset expansion KC Conlon, EL Potter, S Pittaluga, CCR Lee, MD Miljkovic, TA Fleisher, ... Clinical Cancer Research 25 (16), 4945-4954, 2019 | 124 | 2019 |
| Interleukin-15 (dys) regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer TA Waldmann, MD Miljkovic, KC Conlon Journal of Experimental Medicine 217 (1), 2020 | 123 | 2020 |
| Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised … V Granit, M Benatar, M Kurtoglu, MD Miljković, N Chahin, G Sahagian, ... The Lancet Neurology 22 (7), 578-590, 2023 | 114 | 2023 |
| Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade DA Rauch, KC Conlon, M Janakiram, JE Brammer, JC Harding, BH Ye, ... Blood, The Journal of the American Society of Hematology 134 (17), 1406-1414, 2019 | 105 | 2019 |
| End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making C Melani, R Advani, M Roschewski, KM Walters, CC Chen, L Baratto, ... Haematologica 103 (8), 1337, 2018 | 86 | 2018 |
| Potential cost implications for All US Food and drug administration oncology drug approvals in 2018 PC DeMartino, MD Miljković, V Prasad JAMA Internal Medicine 181 (2), 162-167, 2021 | 45 | 2021 |
| Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies SP Dubois, MD Miljkovic, TA Fleisher, S Pittaluga, J Hsu-Albert, BR Bryant, ... Journal for immunotherapy of cancer 9 (4), 2021 | 41 | 2021 |
| Atrial Fibrillation and Stroke Risk in Patients With Cancer: A Primer for Oncologists M Sorigue, MD Miljkovic Journal of Oncology Practice 15 (12), 641-650, 2019 | 34 | 2019 |
| “Allow Natural Death” versus “Do Not Resuscitate”: What Do Patients with Advanced Cancer Choose? MD Miljković, D Emuron, L Rhodes, J Abraham, K Miller Journal of palliative medicine 18 (5), 457-460, 2015 | 34 | 2015 |
| NF-κB–induced R-loop accumulation and DNA damage select for nucleotide excision repair deficiencies in adult T cell leukemia Y He, N Pasupala, H Zhi, B Dorjbal, I Hussain, HM Shih, S Bhattacharyya, ... Proceedings of the National Academy of Sciences 118 (10), e2005568118, 2021 | 32 | 2021 |
| Morphometric study of healthy jejunal and ileal mucosa in adult and aged subjects JB Trbojević-Stanković, NM Milicevic, DP Milošević, N Despotović, ... Histology and histopathology, 2010 | 28 | 2010 |
| Association Between US Drug Price and Measures of Efficacy for Oncology Drugs Approved by the US Food and Drug Administration From 2015 to 2020 MD Miljković, JE Tuia, T Olivier, A Haslam, V Prasad JAMA Internal Medicine 182 (12), 1319-1320, 2022 | 25 | 2022 |
| Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia M Sorigue, L Magnano, MD Miljkovic, J Nieto‐Moragas, M Santos‐Gomez, ... Cytometry Part B: Clinical Cytometry 98 (5), 441-448, 2020 | 23 | 2020 |
| Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL MD Miljkovic, C Melani, S Pittaluga, R Lakhotia, N Lucas, A Jacob, ... Blood Advances 5 (20), 4198-4210, 2021 | 22 | 2021 |
| Novel medical therapies of recurrent and metastatic gastroenteropancreatic neuroendocrine tumors MD Miljković, M Girotra, RR Abraham, RB Erlich Digestive diseases and sciences 57 (1), 9-18, 2012 | 21 | 2012 |
| Phase 1b/2 study of Vipor (Venetoclax, Ibrutinib, prednisone, Obinutuzumab, and Lenalidomide) in relapsed/refractory B-cell lymphoma: safety, efficacy and molecular analysis C Melani, R Lakhotia, S Pittaluga, MD Miljkovic, JD Phelan, JR Muppidi, ... Blood 136, 44-45, 2020 | 20 | 2020 |
| Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignancies MD Miljkovic, SP Dubois, JR Müller, B Bryant, E Ma, KC Conlon, ... Blood Advances 7 (3), 384-394, 2023 | 17 | 2023 |
| Use of endoscopic ultrasound in diagnosing plasmacytoma of the pancreas V Senadhi JOP. Journal of the Pancreas 13 (1), 26-29, 2012 | 15 | 2012 |
thomas A waldmannChief Lymphoid Malignancies Branch National Cancer Institute NIHПотвърден имейл адрес: helix.nih.gov
